Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Priming Dose of Rocuronium and Milliamperage Value for Supramaximal Stimulation of NeuroMuscular Transmission Monitor

NCT05294523 is registered in ClinicalTrials.gov with Taipei Medical University Hospital as lead sponsor.

NCT NCT05294523
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05294523 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Priming Dose of Rocuronium and Milliamperage Value for Supramaximal Stimulation of NeuroMuscular Transmission Monitor
Lead sponsor
Taipei Medical University Hospital
Phase
Not applicable
Overall status
Unknown status
Start date
December 20, 2021
Completion date
December 31, 2024
Enrollment
300 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

neuromuscular blockade